Sentinel node biopsy for melanoma

Sentinel node biopsy in melanoma is not a good prognostic marker for individual patients

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f651 (Published 6 February 2013)
Cite this as: BMJ 2013;346:f651

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Jonathan L Rees, professor of dermatology1
  1. 1University of Edinburgh, Edinburgh EH3 9HA, UK
  1. jonathan.rees{at}ed.ac.uk

Torjesen deserves credit for her article on sentinel node biopsy (SNB) in melanoma,1 but it is sad that medicine needs a journalist to put its own house in order (excepting people like John Meirion Thomas). So much for evidence based medicine.

Other commentators have pointed out that the evidence that …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL